Investigational Drug Information for Pimodivir
✉ Email this page to a colleague
What is the development status for investigational drug Pimodivir?
Pimodivir is an investigational drug.
There have been 5 clinical trials for Pimodivir.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 3rd 2018.
The most common disease conditions in clinical trials are Influenza, Human, Kidney Failure, Chronic, and Liver Diseases. The leading clinical trial sponsors are Janssen-Cilag International NV, Janssen Research & Development, LLC, and [disabled in preview].
There are eight US patents protecting this investigational drug and one hundred and thirty-two international patents.
Summary for Pimodivir
| US Patents | 8 |
| International Patents | 132 |
| US Patent Applications | 51 |
| WIPO Patent Applications | 27 |
| Japanese Patent Applications | 5 |
| Clinical Trial Progress | Phase 1 (2018-01-03) |
| Vendors | 33 |
Recent Clinical Trials for Pimodivir
| Title | Sponsor | Phase |
|---|---|---|
| A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment | Janssen-Cilag International NV | Phase 1 |
| A Study of Orally Administered Pimodivir in Adult Participants With Hepatic Impairment | Janssen-Cilag International NV | Phase 1 |
| A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults | Janssen-Cilag International NV | Phase 1 |
Clinical Trial Summary for Pimodivir
Top disease conditions for Pimodivir
Top clinical trial sponsors for Pimodivir
US Patents for Pimodivir
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Pimodivir | ⤷ Sign Up | Methods of preparing inhibitors of influenza viruses replication | Vertex Pharmaceuticals Incorporated (Boston, MA) | ⤷ Sign Up |
| Pimodivir | ⤷ Sign Up | Aza-pyridone compounds and uses thereof | Alios BioPharma, Inc. (South San Francisco, CA) | ⤷ Sign Up |
| Pimodivir | ⤷ Sign Up | Aza-pyridone compounds and uses thereof | Alios BioPharma, Inc. (South San Francisco, CA) | ⤷ Sign Up |
| Pimodivir | ⤷ Sign Up | Pyridazinone compounds and uses thereof | ALIOS BIOPHARMA, INC. (South San Francisco, CA) | ⤷ Sign Up |
| Pimodivir | ⤷ Sign Up | Methods of preparing inhibitors of influenza viruses replication | Vertex Pharmaceuticals Incorporated (Boston, MA) | ⤷ Sign Up |
| Pimodivir | ⤷ Sign Up | AZA-pyridone compounds and uses thereof | Janssen BioPharma, Inc. (South San Francisco, CA) | ⤷ Sign Up |
| Pimodivir | ⤷ Sign Up | AZA-pyridone compounds and uses thereof | Alios BioPharma, Inc. (South San Francisco, CA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Pimodivir
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Pimodivir | Australia | AU2014348752 | 2033-11-13 | ⤷ Sign Up |
| Pimodivir | Australia | AU2019203656 | 2033-11-13 | ⤷ Sign Up |
| Pimodivir | Australia | AU2021204970 | 2033-11-13 | ⤷ Sign Up |
| Pimodivir | Brazil | BR112016010576 | 2033-11-13 | ⤷ Sign Up |
| Pimodivir | Canada | CA2930297 | 2033-11-13 | ⤷ Sign Up |
| Pimodivir | China | CN105849105 | 2033-11-13 | ⤷ Sign Up |
| Pimodivir | China | CN108276278 | 2033-11-13 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
